name Nustendi). Bempedoic acid was approved for use in the European Union in April 2020, and the combination bempedoic acid/ezetimibe was approved in...
18 KB (1,589 words) - 07:14, 18 July 2024
Bempedoic acid/ezetimibe, sold under the brand name Nexlizet among others, is a fixed-dose combination medication used for the treatment of high cholesterol...
10 KB (782 words) - 06:09, 16 July 2024
Bempedoic acid/ezetimibe/atorvastatin is a combination therapy composed of bempedoic acid, ezetimibe, and atorvastatin. In a randomized study it showed...
2 KB (200 words) - 12:55, 4 January 2024
in the fixed combinations ezetimibe/simvastatin, ezetimibe/atorvastatin, ezetimibe/rosuvastatin, and ezetimibe/bempedoic acid. The most commonly reported...
20 KB (1,819 words) - 11:14, 1 July 2024
"ESPR". The company's main products are NEXLIZET (bempedoic acid and ezetimibe) and NEXLETOL (bempedoic acid), the first approved oral, once-daily, non-statin...
6 KB (569 words) - 12:24, 18 May 2024
only in Japan) Nilemdo (bempedoic acid, only sold in the EU) Nustendi (fixed dose combination of bempedoic acid and ezetimibe) Other Canalia (teneligliptin...
29 KB (2,326 words) - 13:59, 3 May 2024
ATC code C10 (section C10AC Bile acid sequestrants)
C10AX09 Ezetimibe C10AX10 Alipogene tiparvovec C10AX11 Mipomersen C10AX12 Lomitapide C10AX13 Evolocumab C10AX14 Alirocumab C10AX15 Bempedoic acid C10AX16...
4 KB (434 words) - 04:44, 18 December 2023
(approved by the FDA in 2013 homozygous familial hypercholesterolemia.). Bempedoic acid, an ATP citrate lyase inhibitor ATC code C10 Alenghat, Francis J.; Davis...
11 KB (1,251 words) - 17:11, 6 June 2024
transfer protein (MTP) which results in a reduction of LDL plasma levels. Bempedoic acid acts on the cholesterol synthesis pathway upstream of statins at ATP...
30 KB (2,961 words) - 13:47, 30 May 2024